CAS 2023788-19-2

Tirzepatida

Descrição:

Tirzepatida é um novo peptídeo sintético que funciona como um agonista duplo para os receptores do peptídeo semelhante ao glucagon-1 (GLP-1) e do polipeptídeo insulinotrópico dependente de glicose (GIP). É desenvolvido principalmente para o tratamento do diabetes tipo 2 e da obesidade. A substância é caracterizada por sua estrutura única, que permite aumentar a secreção de insulina em resposta às refeições, reduzir os níveis de glucagon e promover a saciedade, ajudando assim no controle glicêmico e na gestão do peso. Tirzepatida tem uma longa meia-vida, permitindo a administração uma vez por semana, o que melhora a adesão do paciente em comparação com medicamentos diários. Seu mecanismo de ação envolve imitar os efeitos dos hormônios incretinas, levando a uma melhora no metabolismo da glicose. Estudos clínicos mostraram eficácia significativa na redução dos níveis de açúcar no sangue e na promoção da perda de peso em indivíduos com diabetes tipo 2. Como qualquer medicamento, os efeitos colaterais potenciais podem incluir problemas gastrointestinais, e é essencial que os pacientes consultem profissionais de saúde para obter aconselhamento personalizado e monitoramento durante o tratamento.

Sinónimos:

• Tianeptine  Sodium

Tirzepatide

CAS: 2023788-19-2

Fórmula: C₂₂₅H₃₄₈N₄₈O₆₈

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 4813.4514

Ref: IN-DA01MVDA

Tirzepatide

CAS: 2023788-19-2

Tirzepatide (LY-3298176) is a dual glucose-dependent polypeptide (GIP) (EC50=0.042 nM) and glucagon-like peptide-1 (GLP-1) (EC50=0.086 nM) receptor agonist.

Fórmula: C₂₂₅H₃₄₈N₄₈O₆₈

Pureza: 99.52% - 99.99%

Cor e Forma: Solid

Peso molecular: 4813.45

Ref: TM-TP1111

Tirzepatide sodium salt

CAS: 2023788-19-2

Fórmula: C₂₂₅H₃₄₈N₄₈O₆₈·Nax

Pureza: ≥ 95.0%

Cor e Forma: White to off-white powder or solid

Peso molecular: 4813.45 (ex. Na)

Ref: 7W-GP2780

Tirzepatide

CAS: 2023788-19-2

Fórmula: C₂₂₅H₃₄₈N₄₈O₆₈

Peso molecular: 4813.53

Ref: 4Z-PT-453001

Tirzepatide sodium

CAS: 2023788-19-2

Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.

Fórmula: C₂₂₅H₃₄₈N₄₈O₆₈•xNa

Pureza: Min. 95 Area-%

Cor e Forma: Powder

Ref: 3D-BT183282

Heavy Tirzepatide (+52Da)

CAS: 2023788-19-2

Heavy Tirzepatide (+52Da)

Pureza: Min. 95%

Peso molecular: 4,862.7 g/mol

Ref: 3D-CRB1301725

Tirzepatide

CAS: 2023788-19-2

Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.

Fórmula: C₂₂₅H₃₄₈N₄₈O₆₈

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 4,813 g/mol

Ref: 3D-FT181880

Tirzepatide acetate

CAS: 2023788-19-2

Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.

Pureza: Min. 95%

Ref: 3D-FT182420